Posted by Michael Wonder on 05 Aug 2015
It's been hailed as a miracle cure for hepatitis C – but comes with a billion-dollar price tag. ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Breakthrough melanoma drug Keytruda has been recommended for a restricted listing on the Pharmaceutical Benefits Scheme, amid a sombre warning ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \5 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \ \P \u \b \l \i \c \space \h \e \a \l \t \h \space \e \x \p \e \r \t \s \space \s \a \y \space \e \f \f \e \c \t \i \v \e \space \n \e \w \space \d \r \u \g \s \space \t \o \space \t \r \e \a \t \space \h \e \p \a \t \i \t \i \s \space \C \space \s \h \o \u \l \d \space \b \e \space \s \u \b \s \i \d \i \s \e \d \space \i \n \space \A \u \s \t \r \a \l \i \a \space \t \o " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
Indicative 1 April 2015 prices resulting from the 2015 April cycle of price disclosure have now been published on the ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Aspen is pleased to announce that certain of its wholly owned Australian subsidiaries (collectively “Aspen Australia”), have entered into an ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\6 \space \M \a \y \space \2 \0 \1 \4 \space \- \ " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
Confirmation of 1 October 2014 new PBS prices resulting from the 2014 October cycle have been published on the price ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Ron Walker's campaign to turn a $150,000-a-year cancer drug into an accessible treatmenthas paid off, with the federal government deciding to list Keytruda on ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Consumers will pay up to 50 per cent less for many common medicines under changes to the Pharmaceutical Benefits Scheme ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\2 \4 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \- \ \A \space \s \m \a \r \t \space \p \h \o \n \e \space \a \n \d \space \t \a \b \l \e \t \space \v \e \r \s \i \o \n \space \o \f \space \t \h \e \space \P \B \S \space \w \e \b \s \i \t \e \space \i \s \space \n \o \w \space \a \v \a \i \l \a \b \l \e \. \space \U \s \e \r \s \space \o \f \space \m \o \b \i \l \e \space \d \e \v \i \c \e \s " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
The agenda for the July 2015 PBAC meeting is now available on the PBS website. ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The January 2015 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. The Schedule includes the ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Fact sheets on the administration, handling and infrastructure fee, premium free dispensing incentive and adjusted tier 2 pricing have been ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The Alliance for Safe Biologic Medicines (ASBM) today condemned recent announcements by Australian Health Minister Sussan Ley and the Pharmaceutical Benefits Advisory Committee (PBAC) ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\N \I \C \E \space \h \a \s \space \p \u \b \l \i \s \h \e \d \space \f \i \n \a \l \space \g \u \i \d \a \n \c \e \space \r \e \c \o \m \m \e \n \d \i \n \g \space \t \h \e \space \u \s \e \space \o \f \space \a \f \l \i \b \e \r \c \e \p \t \ \a \s \space \a \n \space \o \p \t \i \o \n \space \f \o \r \space \t \r \e \a \t \i \n \g \space \p \a \t \i \e \n \t \s \space \w \i \t \h \ \w \e \t \space \a \g \e \- \r \e \l \a \t \e \d \space \m \a \c \u \l \a \r \space \d \e \g \e \n \e \r \a \t \i \o \n \space \( \A \M \D \) \. \ \A \f \l \i \b \e \r \c \e \p \t " ..."]]
Read more →